tiprankstipranks
Olema Pharmaceuticals (OLMA)
NASDAQ:OLMA
US Market
OLMA
Olema Pharmaceuticals
RESEARCH TOOLSreports

Olema Pharmaceuticals (OLMA) Stock News & Sentiment

961 Followers
Olema Pharmaceuticals: Palazestrant Phase III Upside and Differentiated Pipeline Underpin Buy Rating
Premium
Ratings
Olema Pharmaceuticals: Palazestrant Phase III Upside and Differentiated Pipeline Underpin Buy Rating
24d ago
OLMA
Buy Rating Reaffirmed on Palazestrant’s Differentiated Phase 3 Program and Favorable Risk‑Reward Profile for Olema
Premium
Ratings
Buy Rating Reaffirmed on Palazestrant’s Differentiated Phase 3 Program and Favorable Risk‑Reward Profile for Olema
25d ago
OLMA
Maintaining a Buy on Olema: Differentiated Palazestrant Profile Supports Upside Despite Negative Giredestrant Read-Through
Premium
Ratings
Maintaining a Buy on Olema: Differentiated Palazestrant Profile Supports Upside Despite Negative Giredestrant Read-Through
1M ago
OLMA
Constructive Read‑Through From Giredestrant Data Supports Olema’s Palazestrant and Underpins Buy Rating Despite Sector Setbacks
Premium
Ratings
Constructive Read‑Through From Giredestrant Data Supports Olema’s Palazestrant and Underpins Buy Rating Despite Sector Setbacks
1M ago
OLMA
Olema Pharmaceuticals, Inc. (OLMA) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Olema Pharmaceuticals, Inc. (OLMA) Q4 Earnings Cheat Sheet
1M ago
OLMA
Asymmetric Upside on Olema Ahead of Roche’s persevERA Readout: Buy/High Risk Maintained on Palazestrant Optionality
Premium
Ratings
Asymmetric Upside on Olema Ahead of Roche’s persevERA Readout: Buy/High Risk Maintained on Palazestrant Optionality
2M ago
OLMA
Olema Pharmaceuticals CFO Departs; CEO Assumes Interim Role
Premium
Company Announcements
Olema Pharmaceuticals CFO Departs; CEO Assumes Interim Role
2M ago
8K
OLMA
More OLMA News >

OLMA News on the Web

Olema Oncology initiated with a Peer Perform at Wolfe Research
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX), Olema Pharmaceuticals (OLMA) and Medios AG (OtherMEDOF)
TipRanks News
Neutral
Olema Stock Up 242%, but Does a $122 Million Position Suggest More Upside Potential?
The Motley Fool
Neutral
LifeSci Capital Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)
TipRanks News
Neutral
Olema Oncology assumed with a Buy at Jefferies
TipRanks News
Bullish
Olema Pharmaceuticals (OLMA) Loses 33.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks
Bullish
Olema Oncology price target raised to $58 from $55 at JPMorgan
TipRanks News
Bullish
Olema Oncology price target lowered to $27 from $38 at Goldman Sachs
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OLMA’s Media Buzz Sentiment?
Currently, no data Available
What is OLMA’s weekly average amount of articles?
Currently, no data Available
What is OLMA’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
NBIXNeurocrine
STAAStaar Surgical
AORTArtivion
OWLTOwlet
HUMHumana
Showing the stocks with the most bullish news sentiment over the past week